ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2014

Feb 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2014-02-06

Reporting Person: GIVEN BRUCE D (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-06	Common Stock	A	125000	—	Acquired	125000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-06	Stock Options	$14.54	A	50000	Acquired	2024-02-06	Common Stock (50000)	Direct

Footnotes

F1: Represents shares underlying restricted stock unit, which shares will vest over a two year period from date of grant.

F2: Not applicable.

F3: Option vests and becomes exercisable over a four year period from date of grant.

F4: Includes shares underlying other options previously granted.